Static Chart OKYO Pharma Limited

Equities

Market Closed - Nasdaq Other stock markets 04:30:01 2024-06-14 pm EDT			5-day change	1st Jan Change
1.308 ^USD	-3.82%		+3.00%	-26.10%

Mar. 22	H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating	MT
Mar. 22	OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101	CI

Duration

Period